NIH-funded project leads to FDA-approved newborn screening device
A newborn screening device, developed with funding from NICHD's Small Business Innovation Research program, received de novo clearance from the U.S. Food and Drug Administration (FDA) for the detection of lysosomal storage disorders, which injure the brain and nervous system.